Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-08-30, Stock:JNJ, The news for the past five days is as follows:
2021-08-23: NEWS1: Six U.S. states will not join $26 billion opioid settlements with distributors, J&J.NEWS2: Six U.S. states do not join $26 billion opioid settlements with distributors, J&J.NEWS3: Six U.S. states will not join $26 bln opioid settlements with distributors, J&J.NEWS4: FDA's approval of Pfizer vaccine already paving the way for mandates.NEWS5: 15 Best Reopening Stocks to Buy Now.NEWS6: The FDA approval of Pfizer’s COVID-19 vaccine is a ‘critical step forward in vaccine confidence’: Doctor.NEWS7: Pfizer, BioNTech Gain Ahead of FDA’s Full Approval To Covid Shot.
2021-08-24: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan.NEWS3: Doctor: 'If you want to question [the efficacy of vaccines], you’re betting against the house'.NEWS4: Unvaccinated LA residents were 29 times more likely to be hospitalized with COVID-19: CDC study.NEWS5: Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?.NEWS6: Here's Why Theravance Biopharma Stock Is Tanking Today.NEWS7: The covid booster question is one of privilege and we must be very thoughtful about: Doctor.NEWS8: Is JNJ Stock A Buy As Covid Vaccine Recipients Await News On Boosters?.NEWS9: 3 COVID Vaccine Makers to Watch on Pfizer Jab Full FDA Approval.NEWS10: UPDATE 1-With full vaccine approval, U.S. could control COVID by spring 2022 -Fauci.NEWS11: Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study.NEWS12: UPDATE 1-Six U.S. states do not join $26 bln opioid settlements with distributors, J&J.NEWS13: '[Humans] are creating the waves and the strains': Doctor on Delta variant spread.
2021-08-25: NEWS1: Alabama doctor explains COVID-19 situation in the South.NEWS2: Dow Jones Gains, S&P 500, Nasdaq Hit New Highs; These Stocks Rally On House Vote.NEWS3: J&J Covid Booster Generates 'Rapid And Robust' Antibody Response.NEWS4: Dow Jones Gains As Apple Falls; J&J Slips Despite Booster News; These Stocks Pass Buy Points.NEWS5: ‘I am in favor of companies adopting these strong policies about covid vaccination & mandating it’: Doctor.NEWS6: UPDATE 1-J&J says booster dose increased antibodies in early-stage trials.NEWS7: Delta's unvaccinated workers to pay extra $200 on health plan.NEWS8: Nasdaq Holds Gain; Here Are Some Winners From The Infrastructure Bill.NEWS9: 10 Best No-Fee DRIP Stocks to Buy Now.NEWS10: J&J’s latest booster shot news, Moderna pushes for FDA approval, Pentagon’s vaccine mandate.NEWS11: J&J Covid Booster Generates 'Rapid And Robust' Antibody Response.NEWS12: Nasdaq Pares Gains As Stock Advance Slows; This IBD 50 Stock Tops Buy Point.NEWS13: Moderna completes BLA submission for full approval of COVID-19 vaccine.NEWS14: J&J says an extra dose of its COVID-19 vaccine can boost antibody levels.NEWS15: J&J’s Covid Vaccine Booster Shot Increased Antibodies in Early Trials. What Comes Next..NEWS16: 2 Stocks to Help You Build Retirement Wealth.NEWS17: J&J says new data indicates an extra dose of its COVID-19 vaccine can boost antibody levels.NEWS18: Coronavirus tally: Daily average of COVID-19 cases rises to 7-month high, as J&J data supports booster shots.NEWS19: J&J says booster dose increased antibodies in early-stage studies.NEWS20: Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine.NEWS21: Nordstrom, Urban Outfitters Fall Premarket; Dick's Sporting Goods Rises.NEWS22: J&J Gains as Covid Booster Found to Trigger Strong Response.NEWS23: Johnson & Johnson Stock Gains After Promising COVID Booster Shot Data.
2021-08-26: NEWS1: /C O R R E C T I O N -- Johnson & Johnson/.NEWS2: J&J Defeats Effort to Block Texas Corporate Restructuring Move.NEWS3: U.S. judge declines to stop J&J from splitting talc liabilities from main business.NEWS4: Emergency medicine physician: Delta has 'changed the game' for COVID-19.NEWS5: UPDATE 3-U.S. judge declines to stop J&J from splitting talc liabilities from main business.NEWS6: COVID vaccine: Experts debate best timing for booster shots for America.NEWS7: Best practices on how to prove your Covid-19 vaccination status.NEWS8: The cost of being unvaccinated in the U.S..NEWS9: Delta variant surge: 'I wish everyone was mandated to have the vaccine,' says Alabama doctor.NEWS10: Sackler Immunity and a Texas Two-Step Could Tilt Bankruptcy Scales Away From Victims.NEWS11: Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs.NEWS12: J&J (JNJ) Reports Positive Interim Data on COVID Booster Jab.NEWS13: Moderna (MRNA) Seeks Full FDA Approval for COVID-19 Vaccine.NEWS14: U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January.NEWS15: Better Healthcare Stock: Johnson & Johnson vs. Pfizer.NEWS16: 3 Pharma Stocks to Buy With Juicy Dividends.
2021-08-27: NEWS1: SCAN Health Plan CEO on reducing Covid-19 vaccine disparities among minorities.NEWS2: US Judge Allows Johnson & Johnson To Split Talc Powder Liabilities Into New Company.NEWS3: NIH starts study of COVID-19 booster shot in people with autoimmune diseases.NEWS4: Pfizer (PFE) Inks Deal With Eurofarma to Make COVID-19 Vaccine.NEWS5: 3 Top-Quality Dividend Stocks for a Secure Retirement.NEWS6: Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster Data.NEWS7: The Challenges Vaccine Stocks Face As They Try To Fight Delta Variant.NEWS8: 7 Safe Stocks To Buy for an Increasingly Unstable World.

Answer: Rise